The Invesco Perpetual European Equity Income Fund aims to generate a rising level of income, together with long-term capital growth investing primarily into European equities, excluding the UK.
Name | % Net Assets |
---|---|
Novartis | 7.9% |
Roche | 7.7% |
Koninklijke KPN | 4.4% |
TNT | 4.1% |
Bayer | 3.6% |
UPM-Kymmene | 3.5% |
Atlantia | 3.4% |
Repsol | 3.1% |
Thales | 3.0% |
Elisa | 2.7% |
Key | % Net Assets |
---|---|
![]() |
7.9% |
![]() |
7.7% |
![]() |
4.4% |
![]() |
4.1% |
![]() |
75.9% |
Date | 14-Feb-2025 |
---|---|
NAV | 1,581.30p |
Currency | GBP |
Change | 9.34p |
% | 0.59% |
YTD change | 151.15p |
YTD % | 10.57% |
Fund Inception | 18/01/1986 |
---|---|
Fund Manager | Jeffrey Taylor |
TER | 1.69 (31-Dec-2013) |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £20 |
Charges | |
---|---|
Initial | 5.00% |
Annual Mang't | 1.68% |
Exit | n/a |
Name | % |
---|---|
Standard deviation | 0.02 |
Sharpe ratio | 0.10 |
You are here: research